Arcotatug tavatecan improves progression-free survival in CLDN18.2-positive advanced gastric cancer
Arcotatug tavatecan improves progression-free survival in CLDN18.2-positive advanced gastric cancer
Zanidatamab plus chemotherapy improves overall survival in HER2-positive advanced gastroesophageal cancer
Omega-3 EPA improves overall survival after colorectal cancer liver metastasis resection
Reduced dosing frequency of immune checkpoint inhibitors raises survival concerns in advanced cancer
ESMO 2026: Highlights and analysis
Dostarlimab achieves durable complete clinical responses in dMMR/MSI-H locally advanced rectal cancer
UEG 2026: Improving early detection of colorectal cancer
Adagrasib plus cetuximab shows activity but does not improve survival in KRAS G12C-mutated metastatic colorectal cancer
ctDNA MRD status predicts survival and adjuvant chemo benefit in resected colorectal liver metastas
Early ctDNA clearance linked to improved outcomes in KRAS G12C-mutant colorectal cancer
ASCO 2026: Highlights and analysis
Velzatinib demonstrates broad activity across KIT mutations in advanced gastrointestinal stromal tumours